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Introduction
Primary care is often the point of first clinical
contact for patients who are anxious and depressed.
The experience of staff providing care in this setting
is rich and extensive. However, a number of studies
level criticisms at primary care for its management
of anxiety and depression, and undermine claims of
effective care. This article seeks to empower primary
care practitioners, including general practitioners
(GPs), nurses and counsellors, by proposing a model
for anxiety and depression tailored to primary care.
It highlights misguided beliefs and conceptual flaws
inherent in current formulations of anxiety and
depression. Clinical implications of alternative
theories derived from psychobiology that view
these reactions as adaptive responses to adversity
are explored to foster discussion, provide the basis
for future research and to improve education of
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ABSTRACT
Patients who feel anxious and depressed often
turn to primary care for initial professional help.
However, systematic service evaluations allege
poor standards of diagnosis and treatment,
resulting in disappointing clinical outcomes. All
the same, special educational and quality im-
provement initiatives have not raised standards
significantly. Why this should be so and possible
remedies are suggested by this article, on the basis
that the empirical evidence base for criticising
primary care standards is weaker than commonly
acknowledged. Systematic clinical trials are often
premised by assumptions that are not relevant to
primary care, they tend to select subject popu-
lations unrepresentative of those typically seen 
by general practitioners and results are often
compromised by a series of methodological flaws.
This article proposes an alternative conceptual-
isation of anxiety and depression apposite to
primary care assessment and therapy. It draws on
an emergent evidence base within psychobiology
that recognises that these reactions have two
adaptive functions. Firstly, they are responses
evoked by actual personal adversity, secondly they
have the function of prompting communication
to self and to others of the need for practical
remedial action to be taken independently, or
with assistance, to improve the quality of the
recovery environment. A table summarises the
phased stages of anxiety and depression and lists
their adaptive and communicative functions
along with some phase-appropriate primary care
interventions. This new model of assessment and
therapy is offered to stimulate discussion and
inspire future research that is appropriate for
primary care service improvement. 
Keywords: anxiety, assessment, depression,
psychobiology, therapy
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healthcare professionals and hence deliver better
care.
Background
The National Service Framework for Mental Health recog-
nises that initial assessment and therapy for anxiety
and depression is provided in primary care.1 However,
GPs are also criticised for poor clinical management
of these patients, by failing to diagnose these presen-
tations, making incorrect diagnoses, and denying
patients treatments that are considered effective.2–7
Despite considerable efforts to improve the
management of anxiety and depression in primary
care using drug and psychological therapies of
known efficacy, epidemiological surveys claim 
both are increasing in incidence and prevalence.8–13
It is, however, unclear if this is a true change, or a
trend engendered by new screening methodologies.
A recent prediction is that by 2020 the economic
burden attributed to anxiety and depression will be
second only to coronary heart disease.14
This article questions these critical perspectives
and argues that difficulties in managing anxiety and
depression in primary care are largely attributable
to misguided clinical advice derived from psychiatric
illness models of anxiety and depression. Confusion
arises because the basis for current recommendations
is not only conceptually flawed, but also draws on a
weak evidence base that fosters simplistic formula-
tions of personal distress as well as an unwarranted
sense of clinical competence, in an area character-
ised by complex interactions between psychosocial
and biological processes. 
In this article we suggest an alternative model of
assessment and therapy for anxiety and depression
in primary care. It breaks with medical model con-
ventions by emphasising the adaptive function of
evoked reactions to adversity, and enables considera-
tion of alternative options for planning, co-ordinating,
delivering and developing more relevant multidis-
ciplinary services focused on user needs. Table 1 out-
lines clinical actions indicated by the proposed model.
Conceptual confusion and weak
evidence
Advice to primary care teams about how to help
those who feel anxious and depressed is confused
and misguided because studies informing clinical
practice are often carried out in secondary or
tertiary care settings. However, recent publications
document significant differences between these
populations for age and sex, symptom duration 
and severity, patients’ general health and social
functioning.15–23 This cautions against assuming
that findings, conclusions and recommendations
pertinent to secondary and tertiary care are also
relevant to patients in primary care. 
Confusion also arises because the diagnostic lan-
guage of anxiety and depression lacks precision. This
stems from a lack of clarity about whether patients’
complaints are normal feelings, mood states, stable
or volatile personality characteristics, expressions of
reality-based distress or psychiatric illnesses.24 Anxiety
and depression are therefore not easily categorised
into the distinct diagnostic entities that are a pre-
condition for rigorous academic study and con-
fident professional practice in primary care settings. 
The ICD-10 and DSM-IV offer a broad range 
of diagnostic criteria for a variety of presentations
characterised by anxiety and depression.25,26 How-
ever, these are of limited utility in clinical practice
because symptom criteria do not reliably distin-
guish reactions that are transient, self-limiting,
evoked by temporary adversity or that have more
sinister aetiologies requiring onward referral.24,27,28
This is so whether diagnoses are based on informal
assessment, structured clinical interviews or admin-
istration of standardised psychometric question-
naires.29–33
All the same, medical, behavioural and cognitive
models of anxiety and depression construe these
reactions as clinical disorders for which treatment
with medication or psychological therapy is
indicated.34–40 It is no wonder therefore that diag-
nostic guidance and treatment recommendations
for anxiety and depression lack clarity. For instance,
primary care providers operate in a professional
climate of not knowing whether anxiety and depres-
sion are distinct or related clinical phenomena.41–45
Consensus about their role in the aetiology and
treatment of unexplained physical symptoms
remains elusive.46–50 Patients’ complaints are usually
subject to marked fluctuations and those affected
are typically less preoccupied with the frequency or
intensity of symptoms than with pragmatic
considerations of their disruptive effects on day-to-
day functioning.51–56
Effectiveness, efficacy and
clinical guidance
Clinical trials rarely reproduce conditions of primary
care service delivery. Discrepancies arise because
methodological rigor demands patient inclusion
and exclusion criteria that are not generalisable to
primary care. Clinical trials and primary care practice
also differ in respect of the professional status of
care providers, their level of training or experience,
the level of treatment ‘fidelity’ achieved by adher-
ence to research protocols, the capacity and time to
deliver complex psychological assessments and
interventions, as well as the frequency and duration
of interventions being assessed. Other points of
divergence include the management of treatment
dropout, non-compliance and remedial help offered
for treatment-related side-effects.57–61
Group statistical differences and remission rates
are typically quoted as measures of treatment
effectiveness. Although reported with conviction, 
it is questionable if these measures are helpful in
primary care where clinical imperatives dictate
interventions and outcomes that need to be tailored
to the needs and priorities of individual patients.
For instance, a convention exists in outcome studies
to define remission as a 50% reduction in symptom
levels. A likely consequence of advocating treatments
or therapies evaluated according to this arbitrary
benchmark of effectiveness is that many patients
will remain encumbered by clinically significant
residual difficulties for which resolution will, once
again, be sought in primary care. Such outcome
criteria fall short of the standards required to address
practical day-to-day concerns about improving
service delivery in general practice.62–64
Limitations of medical 
model-based clinical guidance
Regarding patients’ feelings of anxiety and depression
as symptoms of illness, rather than adaptive expres-
sions of anguish or despair at a time of personal
crisis, runs the risk of devaluing the communicative
functions of these feelings.65 It may also trivialise
inconvenient complexities inherent in patients’
current life situations and adverse influences ex-
erted by past experience on current adjustment.66–69
The many influences involved in the genesis 
and maintenance of anxiety and depression are
insufficiently recognised in current medical model
formulations presented to GPs. Reductionist
perspectives describing assumed neurobiochemical
correlates are in vogue. This fosters modes of clin-
ical practice in which resolution is primarily sought
through psychopharmacological intervention, and
expectations are mistakenly engendered that
medication is crucial for effecting resolution to
problems. This is not borne out by the evidence, 
but the prevailing drug treatment ethos may unin-
tentionally strengthen placebo effects.70,71 Less
desirable is the time pressure exerted on GPs by
patients seeking medical care for psychosocial ad-
justment difficulties, when public and professional
concerns are being expressed about consultation
times being too short for considered care
planning.2,72,73
A new perspective for clinical
guidance
The pathogenesis of anxiety and depression is not
fully understood, and many factors are involved in
producing these complex reactions. This is clinically
inconvenient and gives rise to the compellingly
attractive allure of seeming certainties of simplistic
formulations. But a failure to recognise their limita-
tions carries a high risk of compromising patient
care. Most likely, both anxiety and depression are
engendered by psychological, social, familial, life-
style, organic and circumstantial factors in dynamic
interaction. From a primary care perspective it is
advantageous to view both conditions as a spectrum
of syndromes of behavioural, cognitive, emotional
and psychosomatic reactions evoked by actual
adversity. 
This link between patient presentations and their
current life situation suggests a changed emphasis
and different approach to assessment. Central to
problem formulation is the skill of eliciting patients’
narrative that recognises, either implicitly or
explicitly, the original circumstances that evoked
their distress, as well as continuing adversities that
maintain their presenting complaints. So construed,
anxiety and depression are expressions of fear,
despair and a sense of having lost control over key
aspects of life. When first reported they present 
an opportunity to bridge a communication gap
between speaker and listener by prompting more
detailed enquiry about matters that may not at first
have been explicitly recognised as important for a
sense of wellbeing. In this sense therefore, the expres-
sion of anxiety and depression is highly functional
and adaptive, most especially if patients’ communi-
cations are responded to as calls for the help and
support that is needed to resolve precipitating
difficulties and their ongoing consequences. 
In general terms, reports of anxiety should prompt
clinical enquiry about current threats to psycho-
logical, social or physical integrity and the extent to
which the patient has the resources required to
restore a sense of personal safety and security.74,75
Reported feelings of depression can be explored as
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communications about life and situational changes
that engender despair and hopelessness.76,77 These
feelings tend to arise under conditions where patients
are not in possession of, or are unable to mobilise,
personal resources to effectively address current ad-
versities, especially if prevailing life circumstances
are perceived as uncontrollable or inescapable.78–81
Given the close thematic similarities between factors
that are cited to account for the genesis and main-
tenance of both anxiety and depression, it is unsur-
prising that many patients present with features of
both. This formulation also clarifies why precipitants
can be psychosocial (separation, threat, financial dif-
ficulty, etc) as well as physical (illness, disability, etc).
In contrast to the biomedical model, this formu-
lation of anxiety and depression paves the way for 
a multidisciplinary approach to care. It is under-
pinned by the salutogenic paradigm of Antonovsky
and acknowledges multiple determinants of health
status.82–84 In so doing it upgrades the clinical value
of assessments and interventions that are becoming
integral to the roles of practice-based nurses and
counsellors as well as other providers of psycho-
logical therapy in primary care. The new model of
service delivery is rooted in recognition of the
adaptive communicative functions served by expres-
sions of anxiety and depression. It also highlights
the importance of non-organic factors contributing
to the genesis, maintenance and resolution of
adjustment difficulties. For instance, understanding
and ameliorating influences exerted by formative
life experiences, taking steps to counteract the
adverse influences that may be exerted by initial
psychological reactions to situational stressors, and
harnessing the remedial influence of social support
hold particular promise in primary care manage-
ment of anxiety and depression.85–87
The clinical significance of
brain–behaviour plasticity 
Central to this new model of anxiety and
depression is the notion that, for all their phased
complexities, human responses evoked by changing
life circumstances serve adaptive functions. Under
circumstances of adversity, adjustments are typically
made to promote coping and survival. The processes
involved are simultaneously psychological and
neurobiological, with a sequential order extending
from fragments of seconds (startle), several seconds
(sympathetic activation), tens of minutes (activation
of the hypothalamic–pituitary–adrenal axis), hours
(for early gene expression), to days (consolidation of
learning) and months (re-adaptation and recovery).88
Only the most acute responses are reflexive.
Subsequent reactions are heavily modulated by
appraisals of threat, the subjective meanings
attributed to unfolding adversities and the extent to
which self-esteem is sustained or strengthened
through effective coping.65,89 The emergent state of
neurobiological, emotional, cognitive and behav-
ioural disequilibrium will either help resolve adversity
or engender persistent feelings of anxiety and
depression.90,91 Sharing these feelings and evoked
reactions is adaptive if communication strengthens
links with possible helpers.
This formulation draws extensively on recent
advances in neurobiology that explain how biology
affects behaviour, and behaviour in turn affects
biology.65 The notion of neuroplasticity allows
adversity to be seen as producing a state of aversive
physical or psychological disequilibrium from
which relief will be sought. Relief can be found if an
individual is in possession of personal or social re-
sources conducive to coping and mastery. Adversities
may be resolved by practical action culminating 
in the re-establishment of a steady state.92 These
principles are embodied in Table 1, which also
offers guidance about assessment and therapy for
those who feel anxious and depressed.
Feelings of anxiety and depression first emerge to
signal adversity. They become consolidated when
these initially adaptive reactions fail to produce pro-
gress towards their resolution. Under such circum-
stances the new model postulates the emergence of
a state of neuro- and psychobiological disequilibrium
that provokes adverse behavioural, cognitive,
emotional and biological reactions. In turn these
exacerbate the subjective sense of adversity and not
coping. Securing help becomes an imperative, and
the more persistent feelings of anxiety or depression
promote survival by prompting help-seeking
behaviour. 
Recent reports document that brain plasticity
increases in adults under conditions of personal
adversity. If no help is offered or accepted, or if it 
is misguided, the effect is to increase the risks of
patients’ presenting problems becoming persistent
and chronic.93,94 Adversity therefore does not only
precipitate initial feelings of anxiety or depression.
It may also, along with altogether different processes
unrelated to precipitation (e.g. anxious and depres-
sive ruminations), continue to exert powerfully
aversive influences after primary care help and support
have been secured.65,95,96 A consideration of patients’
past experiences and ongoing adversities therefore
effectively sets limits for realisable therapeutic out-
comes. In fact, only one-third of those treated with
antidepressant medication alone achieve remis-
sion.60,64,97 This model therefore acknowledges that
we cannot offer guarantees of permanent resolution.
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Primary care assessment,
intervention and therapy
Primary care practice has hitherto largely drawn
inspiration from models of disorder premised by
oversimplified cause–effect relationships. Future
provision should be rooted in rationales drawn
from more complex models of person–environment
relationships and recent advances in our under-
standing about brain–behaviour plasticity. 
This can be achieved by initially carrying out
assessments of those who feel anxious and
depressed using the perspective outlined above and
summarised in Table 1. It features four columns,
each headed by descriptions of progressive stages of
experienced adversity. Each row describes some of
the adaptive challenges presented to anxious and
depressed individuals, their informal support net-
works and roles of primary care professionals. If
scanned vertically, Table 1 presents a summary of
each stage of phased response to adversity and its
distinguishing features. If read horizontally it illus-
trates how patients’ adaptations and needs change
through progressive stages towards resolution of
adversity and relief of evoked distress. The table is
not exhaustive in its details and does not imply an
inevitable sequential progression from one stage to
the next. In reality, listed stages are schematic, over-
laps typically occur and, depending on concurrent
life developments (e.g. a sequence of redundancy,
having financial problems and then being unex-
pectedly bereaved), a patient may change rapidly
from any one stage to any other.
Primary care staff can promote resolution by
focusing on the extent to which reactions evoked
by adversity succeed or fail to engender a sense of
coping and mastery (see Box 1).98 A basic premise in
the new approach is that adaptation and survival is
enhanced through communication with others. Dis-
closure improves adjustment, if talking about current
and past life experiences evokes in listeners a level
of positive concern, and secures help that comple-
ments that which patients mobilise for themselves.
Calls for help and support, expressed in the form of
anxiety and depression, should prompt primary
care staff to consider which of a range of considered
responses may complement the adaptive measures
already taken by patients, their families and net-
works of friends. Reappraisal of current adversities
can be achieved by highlighting how present
emotional states bias perceptions, and how patterns
of communicating with others can be changed so as
to secure more help and support. More detailed
assessment of persistent anxiety or depression may,
for instance, reveal that the manner of approaching
others is having the unintended effect of preventing
solution-focused communication. This is advocated
as an alternative to present preoccupations with the
morphology of symptoms.
Summary, conclusions and
recommendations
This model of anxiety and depression, which we
believe relates more closely to clinical challenges in
primary care settings, conceptualises these feeling
states as natural responses evoked by a life circum-
stance of personal adversity. Past life experience 
also shapes individual reactions to particular life
events. When carrying out clinical assessments, it 
is important to view patients’ reported reactions as
adaptive calls for practical help and supportive care.
Once the link between subjective feeling state and
life circumstance has been made explicit, it is possible
to reach a problem formulation that recognises 
the different courses of practical action that may 
be conducive to re-establishing a state of optimal
personal wellbeing. Table 1 summarises the key
components of this model of anxiety and depres-
sion care. Therapeutic interventions can therefore
take the form of any personal, interpersonal or social
measures that address needs identified in consulta-
tion with patients, and the resolution of which
involves their active participation.99,100
The practical problem–solution-focused inter-
actions advocated in this article strengthen existing
‘common sense’ practices and reinforce the import-
ance of harnessing ‘non-specific therapeutic variables’
in primary care provision. Some aspects of the new,
increasingly patient-focused, phased and needs-
driven support role may change working practices
among members of primary care teams. For instance,
during the phases of ‘confrontation with adversity’
and ‘steps towards resolution’ described in Table 1,
patients may prefer assistance with accessing
information on the internet or leaflets published 
by specialist charities to being prescribed medi-
cation. Griffiths has shown that opening a weekly
‘Information and Benefits Advice Bureau’ in general
practice successfully assisted patients whose health
was being affected by poverty.101 A groundbreaking
clinical initiative suggested by the advocated model
of anxiety and depression in primary care would be
to extend and evaluate practical, problem-focused
innovations that encompass information about 
the links between anxiety and depression and
adversities in patients’ current life situations. This
could be complemented by opportunities to share
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In
it
ia
l 
ca
re
 p
la
n
n
in
g
in the experiences of others who are trying to 
or have taken steps to minimise the impact of
adversity on day-to-day functioning. Improved
information about, or easier access to, resources that
deal with welfare, benefits and legal rights, local
social services, housing provision and police powers
may also impact on presented problems. 
The proposed model of assessment and therapy
for anxiety and depression suggests new avenues for
research in primary care. We believe that the results
of such research will differ markedly from those
studies that are or have been critical of primary care
provision. In consequence, this line of investigation
will engender altogether different guidelines for
primary care management of those who feel anxious
and depressed. Clearly, there is also a need to inves-
tigate the extent to which education and training of
primary care service providers should incorporate
key components of this model. The objective of so
doing would be to foster modes of practice in which
staff feel supported in carrying out collaborative
assessments, agreeing problem formulations which
are relevant to the phased needs of individual
patients, and in collaboration with service users 
and colleagues starting to implement appropriate
action-oriented care plans. 
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